These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 39125279)

  • 1. Therapeutic Potential of Natural Compounds Acting through Epigenetic Mechanisms in Cardiovascular Diseases: Current Findings and Future Directions.
    Bontempo P; Capasso L; De Masi L; Nebbioso A; Rigano D
    Nutrients; 2024 Jul; 16(15):. PubMed ID: 39125279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic-related therapeutic challenges in cardiovascular disease.
    Schiano C; Vietri MT; Grimaldi V; Picascia A; De Pascale MR; Napoli C
    Trends Pharmacol Sci; 2015 Apr; 36(4):226-35. PubMed ID: 25758254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutriepigenetics and cardiovascular disease.
    Kalea AZ; Drosatos K; Buxton JL
    Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):252-259. PubMed ID: 29847446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of redox signaling in epigenetics and cardiovascular disease.
    Kim GH; Ryan JJ; Archer SL
    Antioxid Redox Signal; 2013 May; 18(15):1920-36. PubMed ID: 23480168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of sex dimorphism in cardiovascular health.
    Thej C; Kishore R
    Can J Physiol Pharmacol; 2024 Sep; 102(9):498-510. PubMed ID: 38427976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in epigenetic regulation of vascular aging.
    Jin J; Liu Y; Huang L; Tan H
    Rev Cardiovasc Med; 2019 Mar; 20(1):19-25. PubMed ID: 31184092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of epigenetic modifications in cardiovascular disease: A systematic review.
    Muka T; Koromani F; Portilla E; O'Connor A; Bramer WM; Troup J; Chowdhury R; Dehghan A; Franco OH
    Int J Cardiol; 2016 Jun; 212():174-83. PubMed ID: 27038728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of epigenetics in the management of cardiovascular disease: a review.
    Cao Y; Lu L; Liu M; Li XC; Sun RR; Zheng Y; Zhang PY
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3097-104. PubMed ID: 25392111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics in the primary and secondary prevention of cardiovascular disease: influence of exercise and nutrition.
    Gevaert AB; Wood N; Boen JRA; Davos CH; Hansen D; Hanssen H; Krenning G; Moholdt T; Osto E; Paneni F; Pedretti RFE; Plösch T; Simonenko M; Bowen TS
    Eur J Prev Cardiol; 2022 Dec; 29(17):2183-2199. PubMed ID: 35989414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic associations in relation to cardiovascular prevention and therapeutics.
    Voelter-Mahlknecht S
    Clin Epigenetics; 2016; 8():4. PubMed ID: 26779291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms and Advances of Epigenetic Regulation in Cardiovascular Disease.
    Wang X; Teng X; Luo C; Kong L
    Front Biosci (Landmark Ed); 2024 May; 29(6):205. PubMed ID: 38940023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases.
    Schiano C; Benincasa G; Franzese M; Della Mura N; Pane K; Salvatore M; Napoli C
    Pharmacol Ther; 2020 Jun; 210():107514. PubMed ID: 32105674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics in cardiovascular health and disease.
    Chew NWS; Loong SSE; Foo R
    Prog Mol Biol Transl Sci; 2023; 197():105-134. PubMed ID: 37019589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential epigenetic therapeutics for atherosclerosis treatment.
    Nicorescu I; Dallinga GM; de Winther MPJ; Stroes ESG; Bahjat M
    Atherosclerosis; 2019 Feb; 281():189-197. PubMed ID: 30340764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Regulation in Atherosclerosis.
    Wang C; Wang F; Liu F; Chen S
    Discov Med; 2021; 31(162):45-49. PubMed ID: 34965371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergent expansion of clinical epigenetics in patients with cardiovascular diseases.
    Napoli C; Coscioni E; de Nigris F; Donatelli F
    Curr Opin Cardiol; 2021 May; 36(3):295-300. PubMed ID: 33605616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of epigenetic mechanisms regulated by enhancers and long noncoding RNAs in cardiovascular disease.
    Das S; Reddy MA; Natarajan R
    Curr Opin Cardiol; 2020 May; 35(3):234-241. PubMed ID: 32205477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.
    Xu S; Kamato D; Little PJ; Nakagawa S; Pelisek J; Jin ZG
    Pharmacol Ther; 2019 Apr; 196():15-43. PubMed ID: 30439455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.